WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction

Behavioural Brain Research

Volumn 208, Issue 2, 2010, Pages 584-592

  Robinson, Lianne ^a   Goonawardena, Anushka V ^a,b   Pertwee, Roger ^a   Hampson, Robert E ^a,b   Platt, Bettina ^a   Riedel, Gernot ^a,b  

^a Institute of Medical Science   (United Kingdom)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Cannabinoid; Cholinesterase inhibitor; Rat; Rivastigmine; Spatial learning; Water maze; WIN 55,212 2

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; DIZOCILPINE; DRONABINOL; RIMONABANT; RIVASTIGMINE; SCOPOLAMINE BROMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; COGNITIVE DEFECT; CONTROLLED STUDY; LEARNING DISORDER; LONG TERM MEMORY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REFERENCE MEMORY; SHORT TERM MEMORY; SWIMMING;

ACETYLCHOLINE; ANIMALS; BENZOXAZINES; CHOLINERGIC ANTAGONISTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, CANNABINOID; SCOPOLAMINE; SPATIAL BEHAVIOR;

EID: 77249145318     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.01.004     Document Type: Article

References (60)

1. Ameri A. The effects of cannabinoids on the brain. Progress in Neurobiology 58 (1999) 315-348
2. Bejar C., Wang R.H., and Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. European Journal of Pharmacology 383 (1999) 231-240
3. Braida D., and Sala M. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 11 9 (2000) 2025-2029
4. Breivogel C.S., Griffin G., Di Marzo V., and Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 60 1 (2001) 155-163
5. Brodkin J., and Moerschbacher J.M. SR141716A anatagonises the disruptive effects of the cannabinoid ligands on learning in rats. Journal of Pharmacology and Experimental Therapeutics 282 (1997) 1526-1532
6. 9)-tetrahydrocannabinol in rats. Brain Research 809 1 (1998) 1-4
7. Coutts A.A., and Pertwee R.G. Inhibition by cannabinoid receptor agonists of acetylcholine release from guinea pig myenteric plexus. British Journal of Pharmacology 121 8 (1997) 1557-1566
8. Da Silva G., and Takahashi R.N. SR141716A prevents D9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 26 (2002) 321-325
9. Davies S.N., Pertwee R.G., and Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42 (2002) 993-1007
10. Deadwyler S.A., Heyser C.J., and Hampson R.E. Complete adaptation to the memory disruptive effects of delta-9-THC following 35 days of exposure. Neuroscience Research Communications 17 (1995) 9-18
11. Deiana S., Harrington C.R., Wischik C.M., and Riedel G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology 202 1-3 (2009) 53-65
12. 1, non-CB2 receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry 75 (2000) 2434-2444
13. Fadda P., Robinson L., Fratta W., Pertwee R.G., and Riedel G. Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts. Behavioural Brain Research 168 2 (2006) 307-311
14. Ferrari F., Ottani A., Vivoli R., and Giuliani D. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacology Biochemistry and Behaviour 64 (1999) 555-561
15. Fletcher J.M., Page J.B., Francis D.J., Copeland K., Naus M.J., Davis C.M., et al. Cognitive correlates of long-term cannabis use in Costa Rican men. Archives of General Psychiatry 53 (1996) 1051-1057
16. Gessa G.L., Casu M.A., Carta G., and Mascia M.S. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. European Journal of Pharmacology 355 (1998) 119-124
17. Gessa G.L., Mascia M.S., Casu M.A., and Carta G. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. European Journal of Pharmacology 327 (1997) R1-R2
18. Gifford A.N., and Ashby C.R. Electrically-evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN55,212-2, and is potentiated by the cannabinoid antagonist, SR141716A. Journal of Pharmacology and Experimental Therapeutics 277 (1996) 1431-1436
19. Gifford A.N., Tang Y., Gatley S.J., Volkow N.D., Lan R., and Makriyannis A. Effect of the cannabinoid receptor SPECT agent, AM281, on hippocampal acetylcholine release from rat brain slices. Neuroscience Letters 238 (1997) 84-86
20. Gifford A.N., Bruneus M., Gatley S.J., and Volkow N.D. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes. British Journal of Pharmacology 131 (2000) 645-650
21. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 1 (2001) 1-4
22. Hampson R.E., and Deadwyler S.A. Role of cannabinoid receptors in memory storage. Neurobiology of Disease 5 (1998) 474-482
23. Hampson R.E., and Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sciences 65 6/7 (1999) 715-723
24. Hampson R.E., and Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. The Journal of Neuroscience 20 23 (2000) 8932-8942
25. Hampson R.E., Jarrad L.E., and Deadwyler S.A. Effects of ibotenate hippocampal and extrahippocampal destruction on delayed-match and -nonmatch-to-sample behavior in rats. Journal of Neuroscience 19 (1999) 1492-1507
26. Hironaka N., Tanaka K., Izaki Y., Hori K., and Nomura M. Memory-related acetylcholine efflux from rat prefrontal cortex and hippocampus: a microdialysis study. Brain Research 901 (2001) 143-150
27. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 19 (1999) 4544-4558
28. 1 receptor-deficient mice. British Journal of Pharmacology 132 (2001) 1169-1173
29. Lichtman A.H., Dimen K.R., and Martin B.R. Systemic or intra-hippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119 (1995) 282-290
30. Lichtman A.H., and Martin B.R. D9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126 (1996) 125-131
31. Lichtman A.H. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. European Journal of Pharmacology 404 1-2 (2000) 175-179
32. 1 receptor antagonist SR141716A attenuates the memory impairment produced by D9-tetrahydrocannabinol or anandamide. Psychopharmacology 140 (1998) 11-19
33. 1 receptor antagonist SR141716A on the behaviour of pigeons and rats. Psychopharmacology 124 (1996) 315-322
34. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
35. Miller L.L., and Branconnier R.J. Cannabis: effects on memory and the cholinergic limbic system. Psychological Bulletin 93 (1983) 441-456
36. Mishima K., Egashira N., Hirosawa N., Fujii M., Matsumoto Y., Iwasaki K., et al. Characteristics of learning and memory impairment induced by D9-tetrahydrocannabinol in rats. Japanese Journal of Pharmacology 87 (2001) 297-308
37. Mishima K., Egashira N., Matsumoto Y., Iwasaki K., and Fujiwara M. Involvement of reduced acetylcholine release in D9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life Sciences 72 (2002) 397-407
38. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
39. Nakamura E.M., Da Silva E.A., Concilio G.V., Wilkinson D.A., and Masur J. Reversible effects of acute and long-term administration of D9-tetrahydrocannabinol (THC) on memory in the rat. Drug and Alcohol Dependence 28 (1991) 167-175
40. Nakamura-Palacios E.M., Winsauer P.J., and Moerschbacher J.M. Effects of the cannabinoid ligand SR141716A alone or in combination with D9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys. Behavioural Pharmacology 11 (2000) 377-389
41. Nava F., Carta G., Battesi A.M., and Gessa G.L. D2 dopamine receptors enable D9-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. British Journal of Pharmacology 130 (2000) 1201-1210
42. Nava F., Carta G., Colombo G., and Gessa G.L. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 41 3 (2001) 392-399
43. 1 receptor-dependent and independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN55,212-2. Neuropharmacology 54 (2008) 51-57
44. Pertwee R.G., and Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukotrienes and Essential Fatty Acids 66 (2001) 101-121
45. Pistis M., Ferraro L., Pira L., Flore G., Tanganelli S., Gessa G.L., et al. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research 948 1-2 (2002) 155-158
46. Riedel G., and Davies S.N. Cannabinoid function in learning, memory and plasticity. Handbook of Experimental Pharmacology vol. 168 (2005) pp. 445-477
47. Robinson L., Hinder L., Pertwee R.G., and Riedel G. Effects of delta9-THC and WIN55,212-2 on place preference in the water maze in rats. Psychopharmacology 166 1 (2003) 40-50
48. Robinson L., Harbanan D., and Riedel G. Visual acuity in the water maze: sensitivity to muscarinic receptor blockade in rats and mice. Behavioural Brain Research 151 1-2 (2004) 277-286
49. Robinson L., Platt B., and Riedel G. Cannabinoids. Memories are made of these: from messengers to molecules (2004), Kluwer Academic/Plenum Publishers, New York, USA
50. Robinson L., and Riedel G. Cannabinoid function in spatial learning: an update. Current Neuropharmacology 2 (2004) 125-143
51. Robinson L., Goonawardena A.V., Pertwee R.G., Hampson R.E., and Riedel G. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. British Journal of Pharmacology 151 (2007) 688-700
52. Robinson L., McKillop-Smith S., Ross N.L., Pertwee R.G., Hampson R.E., Platt B., et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl.) 198 4 (2008) 551-563
53. Robson P. Therapeutic aspects of cannabis and cannabinoids. British Journal of Psychiatry 178 (2001) 107-115
54. Roloff E.L., Harbaran D., Micheau J., Platt B., and Riedel G. Dissociation of cholinergic function in spatial and procedural learning in rats. Neuroscience 146 3 (2007) 875-889
55. Ross R.A. The enigmatic pharmacology of GPR55. Trends in Pharmacological Sciences 30 3 (2009) 156-163
56. Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 152 7 (2007) 1092-1101
57. Stiglick A., and Kalant H. Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats. Psychopharmacology 126 (1982) 165-172
58. Sullivan J.M. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. Journal of Neurophysiology 82 (1999) 1286-1294
59. 9THC on spatial reference and working memory in mice. Psychopharmacology 157 (2001) 142-150
60. Wang R.H., Bejar C., and Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39 (2000) 497-506